Helio Health and commercial partner Fulgent Genetics this week announced the launch of the HelioLiver liver cancer blood test. HelioLiver is a multi-analyte blood test that uses cell-free DNA (cfDNA) methylation patterns and serum protein markers to detect hepatocellular carcinoma (HCC), which is the most common form of liver cancer. The test is able to […]